Atlas Trials

Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent

Clinical trial NCT03045510 · UNKNOWN

Trial details

NCT number
NCT03045510
Sponsor
Shandong University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2016-12-01
Primary completion
2018-12-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.